Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions

References

1. 1.↵
   1. Schwartz LM,
   2. Woloshin S

   . Medical marketing in the United States, 1997–2016. JAMA. 2019;321:80–96.

   OpenUrl
2. 2.↵
   1. Mintzes B

   . Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm? Annu Rev Public Health. 2012;33:259–277.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Avery RJ,
   2. Eisenberg MD,
   3. Simon KI

   . The impact of direct-to-consumer television and magazine advertising on antidepressant use. J Health Econ. 2012;31:705–718.

   OpenUrlPubMed
4. 4.↵
   1. Layton JB,
   2. Kim Y,
   3. Alexander GC,
   4. Emery SL

   . Association between direct-to-consumer advertising and testosterone testing and initiation in the United States, 2009–2013. JAMA. 2017;317:1159–1166.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Niederdeppe J,
   2. Byrne S,
   3. Avery RJ,
   4. Cantor J

   . Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin use. J Gen Intern Med. 2013;28:886–893.

   OpenUrlPubMed
6. 6.↵
   1. Kim Y,
   2. Kornfield R,
   3. Shi Y,
   4. et al

   . Effects of televised direct-to-consumer advertising for varenicline on prescription dispensing in the United States, 2006–2009. Nicotine Tob Res. 2016;18:1180–1187.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Daubresse M,
   2. Hutfless S,
   3. Kim Y,
   4. et al

   . Effect of direct-to-consumer advertising on asthma medication sales and healthcare use. Am J Respir Crit Care Med. 2015;192:40–46.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. DeFrank JT,
   2. Berkman ND,
   3. Kahwati L,
   4. Cullen K,
   5. Aikin KJ,
   6. Sullivan HW

   . Direct-to-consumer advertising of prescription drugs and the patient–prescriber encounter: a systematic review. Health Commun. 2019;1–8.
9. 9.↵
   1. Murray E,
   2. Lo B,
   3. Pollack L,
   4. Donelan K,
   5. Lee K

   . Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship. J Am Board Fam Pract. 2004;17:6–18.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Lee D,
    2. Begley CE

    . Racial and ethnic disparities in response to direct-to-consumer advertising. Am J Health-Syst Pharm. 2010;67:1185–1190.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    US Food and Drug Administration. The Office of Prescription Drug Promotion (OPDP). https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-prescription-drug-promotion-opdp. Updated November 4, 2019. Accessed November 21, 2019.
12. 12.↵
    1. Aikin KJ,
    2. Swasy JL,
    3. Braman AC

    . Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs–summary of FDA survey research results. Washington, DC: Food and Drug Administration; 2004.
13. 13.↵
    1. Parekh N,
    2. Shrank WH

    . Dangers and opportunities of direct-to-consumer advertising. J Gen Intern Med. 2018;33:586–587.

    OpenUrl
14. 14.↵
    1. Dillman DA,
    2. Smyth JD,
    3. Christian LM

    . Internet, phone, mail, and mixed-mode surveys: the tailored design method. 4th ed. Hoboken, NJ: John Wiley & Sons; 2014.
15. 15.↵
    1. Gaziano C

    . Comparative analysis of within-household respondent selection techniques. Public Opin Q. 2005;69:124–157.

    OpenUrlCrossRefWeb of Science
16. 16.↵
    1. Ventola CL

    . Direct-to-consumer pharmaceutical advertising: therapeutic or toxic? Pharm Ther. 2011;36:669–674, 681–684.

    OpenUrl
17. 17.↵
    1. Bae J

    . Value-based medicine: concepts and application. Epidemiol Health. 2015;37: e2015014.

    OpenUrl
18. 18.↵
    1. Tourangeau R,
    2. Plewes TJ

    National Research Council. Tourangeau R, Plewes TJ, editors. Nonresponse in social science surveys: a research agenda. Washington, DC: The National Academies Press; 2013.
19. 19.↵
    1. Campbell EG,
    2. Pham-Kanter G,
    3. Vogeli C,
    4. Iezzoni LI

    . Physician acquiescence to patient demands for brand-name drugs: results of a national survey of physicians. JAMA Intern Med. 2013;173:237–239.

    OpenUrl
20. 20.↵
    1. Menchik DA,
    2. Jin L

    . When do doctors follow patients’ orders? Organizational mechanisms of physician influence. Soc Sci Res. 2014;48:171–184.

    OpenUrl
21. 21.↵
    1. Murshid MA,
    2. Mohaidin Z,
    3. Yen Nee G

    . The influence patient’s characteristics “requests and expectations” on physician prescribing behavior: a review. Int J Pharm Health Mark. 2016;10:390–411.

    OpenUrl
22. 22.↵
    1. McKinlay JB,
    2. Trachtenberg F,
    3. Marceau LD,
    4. Katz JN,
    5. Fischer MA

    . Effects of patient medication requests on physician prescribing behavior: results of a factorial experiment. Med Care. 2014;52:294–299.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Ortiz SE,
    2. Rosenthal MB

    . Medical marketing, trust, and the patient-physician relationship. JAMA. 2019;321:40–41.

    OpenUrl